Trials / Completed
CompletedNCT03255863
Determinants of Patients' Uptake of Therapeutic Education Programme
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 459 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Therapeutic Patient Education (TPE) refers to programs that help patients to manage life with a chronic disease in the best possible way. In spite of the effectiveness of Therapeutic Patient Education, few patients uptake TPE when it is proposed to them. Therefore, our main aim was to identify patients' beliefs that will predict patients' uptake of TPE. According to the Health Belief Model, patient will participate in TPE if they perceive their disease as a serious threat (with possible serious complications), but which can be controlled however, and that TPE is efficient and represents little burden. Secondary aims are as follows: 1. To test whether the way TPE is presented to patients impact patients' decision to uptake TPE. The way TPE is presented comprises the time between diagnosis and the proposal of TPE, whether patient is a remission or crisis period in the disease, the time between the proposal and the next TPE session, and what is said by healthcare professionals to present TPE. 2. To test whether healthcare professionals' empathy impact patients' decision to participate in TPE 3. To test whether patients' intention to participate in TPE will predict their actual participation. The ultimate goal of the study is to identify patients whose beliefs will not favor participation in TPE in order to accompany those patients more carefully. Best practices will be proposed according the results.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaire | Patient Self reported questionnaire filled in. |
Timeline
- Start date
- 2017-12-20
- Primary completion
- 2020-09-09
- Completion
- 2020-09-09
- First posted
- 2017-08-21
- Last updated
- 2022-10-17
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03255863. Inclusion in this directory is not an endorsement.